Ofloxamac Eye/Ear Drops contain Ofloxacin (NA), a broad-spectrum fluoroquinolone antibiotic effective against a wide range of Gram-positive and Gram-negative bacterial pathogens. This formulation is indicated for the treatment of bacterial infections of the eye and ear, including conjunctivitis, keratitis, blepharitis, otitis externa, and otitis media. Ofloxacin exerts its antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair, thereby preventing bacterial cell proliferation. The drops are designed for topical administration, ensuring high local concentrations at the site of infection with minimal systemic absorption. Ofloxamac Eye/Ear Drops are generally well tolerated; however, patients may experience mild transient irritation, burning, or discomfort upon instillation. It is contraindicated in individuals with known hypersensitivity to ofloxacin or other quinolones. Caution is advised in patients with a history of tendon disorders related to quinolone use. Proper administration technique should be followed to avoid contamination and ensure efficacy. Treatment duration should be adhered to as prescribed to prevent resistance development. Ofloxamac Eye/Ear Drops provide an effective therapeutic option for managing bacterial infections of the ocular and aural regions, promoting rapid resolution of symptoms and restoration of normal function.